New Radiopharmaceutical Production Unit
A Pipeline Notice
by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST
- Source
- Contracts Finder
- Type
- Potential Contract (Notspecified)
- Duration
- 8 day
- Value
- £50M
- Sector
- HEALTH
- Published
- 29 Jun 2023
- Delivery
- 28 Jun 2023 to 06 Jul 2023
- Deadline
- n/a
Concepts
Location
1 buyer
- Guys & St Thomas NHS Trust London
Description
The Authority, Guy's and St Thomas' NHS Foundation Trust (GSTT) is seeking expressions of interest from strategic and operational industry partners for the provision of Radiopharmacy (RP) services which ensure the realisation of the service's ambition: 'To develop a new, purpose-built, GMP compliant Radiopharmaceutical Production Unit for the aseptic manufacture of radiopharmaceuticals. The unit is to realise the productivity and commercial potential of the Radiopharmacy department and become an exemplar NHS Nuclear Medicine Unit providing training and education opportunities to the next generation of Radiopharmacists. ' The Unit will ensure equity of patient access to the increasing pipeline of RP diagnostics and therapeutics over the next 15-20 years and deliver the most innovative clinical research at its Investigational Medicinal Products (IMP) and Specials licensed facilities. Radiopharmacy sits in the Integrated and Specialist Medicine (ISM) directorate at GSTT, within CLIMP (Clinical Imaging and Medical Physics), and is part of the Nuclear Medicine Department based in the Borough Wing at Guy's Hospital. The unit manufactures tracers used in diagnostics scans, which are used to detect a wide range of conditions (including injuries; infections; tumours; heart disease; thyroid abnormalities; and kidney conditions) and also guide some cancer procedures.
CPV Codes
- 85149000 - Pharmacy services
Indicators
- Contract is suitable for SMEs.
Other Information
Aim of this PIN is to notify the Radio Pharmacy manufacturing market of our intention to commission a Managed Service Agreement for a new aseptic manufacturing unit. Guys and St Thomas NHS Foundation trust's generic principals for MSAs 1. The Trust gives no guarantee around patient activity / volumes. 2.The providers realise returns on any capital investment through service revenues 3. The Provider takes the risk of under payment 4. The Trust takes risk of over payment 5. The trust is to maintain clinician choice where possible i.e. For consumables, equipment, etc that is supplied by the Managed Service Provider. This is a vital stage of our scoping as industry have the opportunity to influence shape the business model of a new Radio Pharmacy manufacturing unit. Significant capital investment will need to be provided by industry to build a new, future proof unit, equipment and consumables. Full or part service management will also include logistics and distribution and the authority will favour those industry partners that recognise the value of Research, clinical studies, education and training. At time of writing there are no available locations at either Guys or St Thomas for a new manufacturing unit and so a location will need to be identified. There is no capital available from GSTT. To get involved in this PIN (IMPORTANT): Please undertake the following steps: 1. Contact Patric Lemagnen (contact details in this notice), and state you are a supplier who is wanting to get involved in this pre-market engagement exercise. 2. Please provide your company details, along with a contact person and email address (this will be the email address which is then added to Atamis). 3. Once you have access to the PIN document on Atamis (saved in the Documents section of the project you'll be added to), please complete the PIN Questionnaire (Section 2; pages 5-6 of the document) and upload your response as an attachment to a message on Atamis. 4. If we have any further questions, or decide to host a supplier engagement event off the back of the responses, we will reach out to you directly.
Reference
- CF-1689600D0O000000rwimUAA
- CF 4de2046d-8342-4052-8577-6b5549d9570c